Publications in collaboration with researchers from University Hospital of Zurich (4)

2019

  1. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    American Heart Journal, Vol. 213, pp. 35-46

2017

  1. Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry

    BMJ Open, Vol. 7, Núm. 3

2015

  1. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation

    Circulation: Cardiovascular Quality and Outcomes, Vol. 8, pp. S12-S20

2003

  1. Design and baseline characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

    Cerebrovascular Diseases, Vol. 16, Núm. 4, pp. 389-395